4,317 results on '"Berg, Thomas"'
Search Results
2. Virtue and Grace in the Theology of Thomas Aquinas by Justin M. Anderson (review)
3. The typology of adjective linkage: Relating NPs to VPs: Supplemental material
4. Amoris Laetitia , Pastoral Discernment, and Thomas Aquinas
5. Das intrahepatische Cholangiokarzinom als eigenständige Entität
6. A Revised Analysis of the “Phoenix Abortion Case” and a Critique of New Natural Law Intentionality
7. Development of a Proof-of-Concept Multi-Method Computer Simulation to Support Rural Healthcare Disaster Preparedness Planning
8. Impact of IL-8 on survival after TARE in HCC: a comprehensive investigation and external validation from the SORAMIC trial
9. RELIGIOUS LIBERTY APOLOGETICS
10. Patient profiled data for treatment decision-making: valuable as an add-on to hepatitis C clinical guidelines?
11. Sex hormones differently regulate lipid metabolism genes in primary human hepatocytes
12. Basal MET phosphorylation is an indicator of hepatocyte dysregulation in liver disease
13. Kombinationstherapie von Tremelimumab und Durvalumab bei nicht resektablem HCC
14. Use of Bacterial DNA Concentration in Ascites as a Marker for Spontaneous Bacterial Peritonitis
15. Buffer-free high pH mobile phase LC-MS/MS for determination of the alcohol biomarker phosphatidylethanol 16:0/18:1 and 20 drugs and metabolites in whole blood
16. Änderungen zur Nomenklatur für Fettlebererkrankungen
17. EASL Clinical Practice Guidelines on liver transplantation
18. A global initiative for ecological and evolutionary hologenomics
19. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients
20. The GALAD score and the BALAD-2 score correlate with transarterial and systemic treatment response and survival in patients with hepatocellular carcinoma
21. Changes of the bacterial composition in duodenal fluid from patients with liver cirrhosis and molecular bacterascites
22. The Application of Model-Based Systems Engineering to Rural Healthcare System Disaster Planning: A Scoping Review
23. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
24. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease
25. Niebuhr’s Christian Realism on Religion, Politics, and Today’s Crises
26. Comparative Evaluation of Multimarker Algorithms for Early-Stage HCC Detection in Multicenter Prospective Studies
27. PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
28. HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
29. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
30. An accurate and precise liquid chromatography–tandem mass spectrometry method for the determination of six phosphatidylethanol homologues in whole blood with phospholipid interferences minimized
31. Prognostic value of baseline MRI features in patients treated with thermal ablation for hepatocellular carcinoma
32. Granulocyte colony stimulating factor in decompensated cirrhosis, acute alcoholic hepatitis, and acute-on-chronic liver failure: A comprehensive meta-analysis of randomized controlled trials
33. HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
34. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
35. Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022
36. A global research priority agenda to advance public health responses to fatty liver disease
37. Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression
38. Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
39. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
40. Cell-based BSEP trans-inhibition: A novel, non-invasive test for diagnosis of antibody-induced BSEP deficiency
41. A new machine-learning-based prediction of survival in patients with end-stage liver disease
42. Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
43. A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B
44. Treating hepatitis D with bulevirtide – Real-world experience from 114 patients
45. High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis
46. Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
47. G-CSF treatment in decompensated liver disease: a double-edged sword?
48. Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial
49. Leber
50. Adressen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.